These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12171541)

  • 21. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
    Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
    Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced COX-2 protein in colorectal cancer with defective mismatch repair.
    Karnes WE; Shattuck-Brandt R; Burgart LJ; DuBois RN; Tester DJ; Cunningham JM; Kim CY; McDonnell SK; Schaid DJ; Thibodeau SN
    Cancer Res; 1998 Dec; 58(23):5473-7. PubMed ID: 9850081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation.
    Brown WA; Skinner SA; Malcontenti-Wilson C; Vogiagis D; O'Brien PE
    Gut; 2001 May; 48(5):660-6. PubMed ID: 11302965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
    Sheng H; Shao J; Kirkland SC; Isakson P; Coffey RJ; Morrow J; Beauchamp RD; DuBois RN
    J Clin Invest; 1997 May; 99(9):2254-9. PubMed ID: 9151799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
    Taketo MM
    J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New anti-inflammatory analgetics--are they needed?].
    Paakkari I
    Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
    [No Abstract]   [Full Text] [Related]  

  • 29. Meloxicam inhibits the growth of colorectal cancer cells.
    Goldman AP; Williams CS; Sheng H; Lamps LW; Williams VP; Pairet M; Morrow JD; DuBois RN
    Carcinogenesis; 1998 Dec; 19(12):2195-9. PubMed ID: 9886578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thinking about the specific cyclooxygenase-2 inhibitors since its recommendation].
    Shi G
    Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):579-80. PubMed ID: 11758234
    [No Abstract]   [Full Text] [Related]  

  • 31. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention.
    Reddy BS; Hirose Y; Cohen LA; Simi B; Cooma I; Rao CV
    Cancer Res; 2000 Sep; 60(17):4792-7. PubMed ID: 10987288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer research. Anti-inflammatories inhibit cancer growth--but how?
    Marx J
    Science; 2001 Jan; 291(5504):581-2. PubMed ID: 11233414
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulation of COX and LOX by curcumin.
    Rao CV
    Adv Exp Med Biol; 2007; 595():213-26. PubMed ID: 17569213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of cyclooxygenase-2 activity in HT-29 human colorectal carcinoma cells.
    Hsi LC; Baek SJ; Eling TE
    Exp Cell Res; 2000 May; 256(2):563-70. PubMed ID: 10772828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cyclooxygenase inhibitors].
    Eschwège P; de Ledinghen V; Camilli T; Kulkarni S; Dalbagni G; Droupy S; Jardin A; Benoît G; Weksler BB
    Presse Med; 2001 Mar; 30(10):515-7. PubMed ID: 11307498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells.
    Zhang F; Altorki NK; Mestre JR; Subbaramaiah K; Dannenberg AJ
    Carcinogenesis; 1999 Mar; 20(3):445-51. PubMed ID: 10190560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COX-2: a molecular target for colorectal cancer prevention.
    Brown JR; DuBois RN
    J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors.
    Richter M; Weiss M; Weinberger I; Fürstenberger G; Marian B
    Carcinogenesis; 2001 Jan; 22(1):17-25. PubMed ID: 11159736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer and cyclooxygenase-2 (COX-2) inhibition.
    Evans JF; Kargman SL
    Curr Pharm Des; 2004; 10(6):627-34. PubMed ID: 14965325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells.
    Park C; Kim GY; Kim GD; Choi BT; Park YM; Choi YH
    Oncol Rep; 2006 May; 15(5):1225-31. PubMed ID: 16596191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.